Company Filing History:
2 out of 22 
1 out of 3 Years Active: 2023-2025
Title: Innovations by Erik Michael Whiteley
Introduction
Erik Michael Whiteley is an accomplished inventor based in Concord, CA, with a focus on advancements in stem cell research. He holds three patents that contribute significantly to the field of regenerative medicine. His work primarily revolves around the differentiation of pluripotent stem cells, which has implications for treating various neurological conditions.
Latest Patents
Whiteley's latest patents include methods for differentiating pluripotent stem cells in dynamic suspension culture. These methods utilize small molecule or protein inhibitors of TGFβ/Activin/Nodal signaling and BMP signaling. The patents provide protocols for differentiating human embryonic stem cells first to neuroectoderm, then to glial progenitor cells, and finally to oligodendrocyte progenitor cells (OPCs). Notably, these methods reproducibly produce neuroectoderm progenitor cells by day 7, glial progenitor cells by day 21, and OPCs by day 42 of the differentiation process. Additionally, he has developed compositions comprising a population of oligodendrocyte progenitor cells, which are useful in treating conditions such as stroke, spinal cord injury, and multiple sclerosis.
Career Highlights
Throughout his career, Whiteley has worked with notable companies in the biotechnology sector, including Asterias Biotherapeutics, Inc. and Lineage Cell Therapeutics, Inc. His contributions to these organizations have been instrumental in advancing their research and development efforts in cell therapy.
Collaborations
Whiteley has collaborated with esteemed colleagues such as Nathan C. Manley and Uzma Shoukat-Mumtaz. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.
Conclusion
Erik Michael Whiteley's work in stem cell differentiation and regenerative medicine showcases his commitment to advancing healthcare solutions. His patents and collaborations reflect a significant contribution to the scientific community and the potential for impactful therapies.